001. Ader, R. (Ed.) Psychoneuroimmunology (Behavioral Medicine Series), New York: Academic Press, 1981.

002. Ader, R. & Cohen, N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science, 215: 1534-1536, 1982.

003. Ahquist, R.P. A study of the adrenotropic receptors. American Journal of Physiology, 153: 586-600, 1948.

003a Alloy, L. B. & Abrahamson, L. Y. (1982) Learned helplessness, depression, and the illusion of control. Journal of Personality and Social Psychology, 42, 1114-1126.

004. Almon, R. R., Andrew, C. G. & Appel, S. H. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science, 186: 55-57, 1974.

005. Anisman, H. Vulnerability to depression: contribution of stress. In Post, R. M. & Ballenger, J. C. (Eds.), Neurobiology of Mood Disorders (Vol. 1; Ch. 27). Baltimore: William & Wilkins, 1984.

006. Anisman, H. & Sklar, L. S. Catecholamine depletion in mice upon reexposure to stress: mediation of escape deficits produced by inescapable shock. Journal of Comparative and Physiological Psychology, 93: 610-625, 1979.

007. Appleton, J. A. & McGregor, D. D. Rapid expulsion of Trichinella spiralis in suckling rats. Science, 226: 70-72, 1984.

008. Arditi, M. & Killner, M. S. (1987). Coma following use of rubbing alcohol for fever control. American Journal of Diseases in Children, 141, 237-238, 1987.

009. Aronow, L. Alcoholism, Alcohol Abuse, and Related Problems: Opportunities for Research. Washington, D.C.: National Academy of Sciences, National Academy Press, 1980.

010. Ax, A. F. The physiological differentiation of fear and anger in humans. Psychosomatic Medicine, 15: 433-442, 1953.

011. Bacopoulos, N. C., Spokes, E. G., Bird, E. D. & Roth, R. H. Antipsychotic drug action in schizophrenic patients: Effect on cortical dopamine metabolism after long-term treatment. Science, 205: 1405-1407, 1979.

011b Baldessarini, R. J. (1980) Drugs and the treatment of psychiatric disorders. In Gilman, A. G., Goodman, L. S. and Gilman, A. (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics (6th Ed. Pp. 391-447). New York: Macmillan, 1980.

011a Braestrup, C. & Squires, R. F. Pharmacological characterization of benzodiazepine receptors in the brain. European Journal of Pharmacology, 48:263-270, 1978.

012. Benes, F. M., Paskevitch, P. A. & Domesick, V. B. Haloperidol-induced plasticity of axon terminals in rat substantia nigra. Science, 221: 969-971, 1983.

013. Berger, H. Ueber das Elektroenkephalogramm des Menschen. Journal of Psychology and Neurology, 40: 160-179, 1930.

014. Bernard, C. Analyse physiologique proprietes des systemes musculaire et nerveux au moyer du curare. C. R. Acad. Sci. (Paris), 43: 825-829, 1856.

015. Bleuler, E. Dementia Praecox or the Group of Schizophrenias. New York: International Universities Press, 1950.

016. Bloom, F. E., Lazerson, A. & Hofstader, L. Brain, mind, and behavior. New York, NY: Freeman, 1985.

017. Bozarth, M. A. & Wise, R. A. Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science, 224: 514-516, 1984.

018. Brady, J. V. Ulcers in executive monkeys. Scientific American, 199: 95-100, 1958.

019. Brazier, M.A.B. A history of neurophysiology in the 17th and 18th centuries: From concept to experiment. New York, NY: Raven, 1984.

020. Brodeur, J. & DuBois, K. P. Studies on the mechanism of acquired tolerance by rats to O,O-diethyl S-2-(ethylthio)ethyl phosphorodithioate (Di-Syston). Archives Internationales de Pharmacodynamie et de Therapie, 149: 560, 1964.

021. Bueno, O. F. & Carlini, E. A. Dissociation of learning in marijuana tolerant rats. Psychopharmacologia, 25: 49-56, 1972.

022. Buisseret, P. D. Allergy. Scientific American, 247: 86-95, 1982.

023. Buisseret, P. D. Common manifestations of cow's milk allergy in children. Lancet, 1(8059): 304-305, 1978.

025. Bunney, B. S. Antipsychotic drug effects on the electrical activity of dopaminergic neurons. Trends in Neuroscience, 7: 212-215, 1984.

026. Butler, R. A. Exploratory and related behavior: A new trend in animal research. Journal of Individual Psychology, 14: 111-120, 1958.

027. Caldwell, A. E. (1970). Origins of Psychopharmacology from CPZ to LSD. Springfield: C. C. Thomas.

028. Campbell, J. C. and Seiden, L. S. Performance influence on the development of tolerance to amphetamine. Pharmacology, Biochemistry, and Behavior, 1: 703-708, 1973.

029. Campbell, B. A., Lytle, L. D. & Fibiger, H. C. Ontogeny of adrenergic arousal and cholinergic inhibitory mechanisms in the rat. Science, 166: 635-637, 1969.

030. Cannon, W. B. Bodily Changes in Pain, Hunger, Fear and Rage. New York: Appleton, 1929.

030b. Cannon, W. B. (1932) The wisdom of the body. New York: Raven.

031. Cannon, W. B. Voodoo death. American Anthropologist, 44: 169-181, 1942.

032. Cannon, W. B. The James-Lange theory of emotions: a critical examination and an alternative theory. American Journal of Psychology, 39: 106-124, 1927.

033. Carlton, P. L. & Wolgin, D. L. Contingent tolerance to the anorexigenic effects of amphetamine. Physiology and Behavior, 7: 221-223, 1971.

034. Carlton, P. L. Brain acetylcholine and inhibition. In Tapp, J. (Ed.): Reinforcement and Behavior, New York: Academic Press, Pp. 288-325, 1969.

035. Carlton, P. L. Cholinergic mechanisms in the control of behavior by the brain. Psychological Review, 40: 19-39, 1963.

036. Carroll, B. J., Curtis, G. C. & Mendels, J. Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Archives of General Psychology, 33: 1051-1057, 1973.

037. Cerletti, U. & Bini, L. L'Elettroshock. Archivio generale di neurologia e psichiattria e psicoanalisi, 19: 266-268, 1938.

038. Clarke, G. The use of the Horsley-Clarke instrument on the rat. Science, 90: 92, 1939.

039. Cook, L. & Sepinwall, J. Reinforcement schedules and extrapolation to humans from animals in behavioral pharmacology. In Weiss, B. & Laties, V. G. (Eds.) Behavioral pharmacology: The current status. New York, NY: Plenum, 1976.

039a. Creese, I., Burt, D. R. & Snyder, S. H. Dopamine receptor binding predicts clinical and pharmacological properties of antipsychotic drugs. Science, 192:481-483, 1976.

040. Geller, I., Kulak, J. T. Jr., & Seifter, J. The effects of chlordiazepoxide and chlorpromazine on a punishment discrimination. Psychopharmacologia (Berlin), 3: 374-385, 1962.

041. Coyle, J. T., Price, D. L. & DeLong, M. R. Alzheimer's disease: A disorder of cholinergic innervation. Science, 219: 1184-1190, 1983.

042. Dalal, A. S. & Barber, T. X. Yoga, yogic feats, and hypnosis in the light of empirical research. In, Barber, T. X., DiCara, L. V., Kamiya, J., Miller, N. E., Shapiro, D. & Stoyva, J. (Eds.) Biofeedback and Self-Control. Chicago: Aldine-Atherton, Pp. 690-701, 1972.

043. Dale, H. H. The action of certain esters and ethers of choline and their relation to muscarine. Journal of Pharmacology and Experimental Therapeutics, 6: 147-190, 1914.

044. Davis, W. M. Day-night periodicity in pentobarbital response of mice and influence of socio-psychological conditions. Experientia, 18: 235-237, 1962.

044b. Delay, J. & Deniker, P. (1952) Trente-huit cas de psychoses traitees par la cure prolongee et continue de 4560 R. P. Compte Rendu du Congres Alien Neurol France, 50, 503-513.

045. Dement, W. C. & Kleitman, N. Cyclic variations in EEG during sleep and their relations to eye movements, body motility and dreaming. Electroencephalography and Clinical Neurophysiology, 9: 673-690, 1957.

046. Dement, W. C. Some Must Watch While Some Must Sleep. San Francisco: Freeman, 1974.

047. Douglas, W. W. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In Gilman, A. G., Goodman, L. S. and Gilman, A. (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics (6th Ed.). New York: Macmillan, 1980, pp 609-646.

048. Durham, W. H. The coevolution of yam festivals and sickle cell frequencies in West Africa. American Journal of Physical Anthropology, 57: 183, 1982.

049. Ekman, P., Levenson, R. W. & Friesen, W. V. Autonomic nervous system activity distinguishes among emotions. Science, 221: 1208-1210, 1983.

050. Elliot, T. R. The action of adrenalin. Journal of Physiology (London), 32: 401-467, 1905.

051. Ellison, G., Eison, M. S., Huberman, H. S. & Daniel, F. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science, 201: 276-278, 1978.

052. Evans, W. O. A new technique for the investigation of some analgesic drugs as a reflexive behavior in the rat. Psychopharmacologia, 2: 318-324, 1961.

053. Falk, J. L. & Burnidge, G. K. (1970). Fluid intake and punishment attenuating drugs. Physiology and Behavior, 5, 199-202.

054. Feigley, D. A. & Hamilton, L. W. Response to novel environments following septal lesions or cholinergic blockade in rats. Journal of Comparative and Physiological Psychology, 76: 496-504, 1971.

055. Flourens, M. J. P. Recherches experimentales sur les proprietes et les fonctions du systeme nerveaux dans les animaux vertebres. Paris: Crevot, 1824.

056. Forman, R. L. & Kelsey, J. E. Blockade of opioid analgesic systems by naltrexone and arcuate nucleus lesions enhances nonopioid analgesia. Personal communication, 1983.

057. Franz, D. N. Central nervous system stimulants. In Gilman, A. G., Goodman, L. S. and Gilman, A. (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics (6th Ed.). New York: Macmillan, Pp. 585-591, 1980.

058. Fritsch, G. & Hitzig, E. Ueber die elektrische Erregbarkeit des Grosshirns. Archiv fuer Anatomie, Physiologie und Wissenschaftliche Medizin, 37: 300-332, 1870.

059. Funkenstein, D. H. The physiology of fear and anger. Scientific American, 192: 74-80, 1955.

060. Geller, I. & Seifter, J. The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia (Berlin), 1: 482-492, 1960.

061. Geschwind, N. & Behan, P. Left-handedness: Association with immune disease, migraine, and developmental learning disorder. Proceedings of the National Academy of Sciences (US), 79: 5097-5100, 1982.

062. Gilman, A. G., Goodman, L. S. and Gilman, A. (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics (6th Ed.). New York: Macmillan, 1980.

063. Glassman, A. H., Jackson, W. K., Walsh, B. T., Reese, S. P. & Rosenfeld, B. Cigarette craving, smoking withdrawal and clonidine. Science, 226: 864-866, 1984.

064. Glowa, J. R. & Barrett, J. E. Drug History modifies the behavioral effects of pentobarbital. Science, 220: 333-335, 1983.

065. Goldberg, S. R., Spealman, R. D. & Goldberg, D. M. Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science, 214: 573-575, 1981.

066. Goldstein, A., Lowney, L. I. & Pal, B. K. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of the mouse brain. Proceedings of the National Academy of Sciences (USA), 68: 1742-1747, 1971.

067. Goleman, D. Staying up: The rebellion against sleep's gentle tyranny. Psychology Today, Pp. 24-35, MAR, 1982.

068. Gray, J. A. Sodium amobarbital, the hippocampal theta rhythm, the partial reinforcement extinction effect and the psychophysiological nature of introversion. Psychological Review, 77: 465-480, 1970.

069. Grossman, S. P. Eating or drinking elicited by direct adrenergic or cholinergic stimulation of hypothalamus. Science, 132: 301-302, 1960.

070. Grulee, C. G. Breast feeding. Proceedings of the International Assembly of Inter-State Post Graduate Medical Association of North America, Pp. 135-137, 1943.

071. Hamilton, L. W. & Timmons, C. R. Maturation of startle reflex habituation in rats. Bulletin of the Psychonomic Society, 14: 427-430, 1979.

072. Harlow, H. F. & Suomi, S. J. Production of depressive behavior in young monkeys. Journal of Autism and Childhood Schizophrenia, 1: 246-255, 1971.

073. Heston, L. L. The genetics of schizophrenic and schizoid disease. Science, 167: 249-256, 1970.

074. Hetherington, A. W. & Ranson, S. W. Hypothalamic lesions and adiposity in the rat. Anatomical Record, 78: 149, 1940.

075. Hoekfelt, T., Johansson, O. & Goldstein, M. Chemical anatomy of the brain. Science, 225: 1326-1334, 1984.

075a. Hoekfelt, T. (1987) Neuronal communication through multiple coexisting messengers. In G. G. Edelman, W. E. Gall, & W. M. Cowan (Eds) Synaptic Function, (pp. 179-211). New York: Wiley.

076. Hollister, L. E. (1962) Drug-induced psychoses and schizophrenic reactions: A critical comparison. Annals of the New York Academy of Sciences, 96: 80, 1962.

077. Horowitz, G. P. & Whitney, G. Alcohol-induced conditioned aversion: Genotype specificity in mice (Mus musculus). Journal of Comparative and Physiological Psychology, 95:104-113, 1975.

078. Horsley, V. & Clarke, R. H. The structure and functions of the cerebellum examined by a new method. Brain, 31: 45-124, 1908.

079. Houston, R. G. Sickle cell anemia and dietary precursors of cyanate. American Journal of Clinical Nutrition, 26: 1261, 1973.

080. Hughes, J. W., Smith, T., Kosterlitz, H., Fothergill, L., Morgan, B. & Morris, H. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature, 255: 577-579, 1975.

081. Hull, C. L. A Behavior System. New Haven: Yale University Press, 1952.

082. Jacobson, M. & Hunt, K. R. The origins of nerve-cell specificity. Scientific American, : 26-36, 1965.

083. Jaffe, J. H. & Martin, W. R. Opioid analgesics and antagonists. In: Gilman, A. G., Goodman, L. S. and Gilman, A. (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics (6th Ed.). New York: Macmillan, 1980. Ch. 7: Pp. 494-534.

084. Jaffe, J. H. Drug addiction and drug abuse. In Gilman, A. G., Goodman, L. S. and Gilman, A. (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics (6th Ed.). New York: Macmillan, Pp. 535-584, 1980.

085. James, W. The Principles of Psychology. New York: Henry Holt, 1890.

086. Janowsky, D.S., El-Yousef, M. K. & Davis, J. M. (1972). The elicitation of psychotic symptomology by methylphennidate. Comprehensive Psychiatry, 13: 83.

087. Jouvet, M. & Pujol, J. F. Effects of central alterations of serotonergic neurons upon the sleep-waking cycle. In Costa, E., Gessa, G. L. & Sandler, M. (Eds.), Serotonin--New Vistas (Advances in biochemical pharmacology, Vol. 11), Pp. 199-209. New York: Raven, 1974.

088. Kalat, J. W. Letter to the editor: Speculation on similarities between autism and opiate addiction. Journal of Autsism and Childhood Schizophrenia. 8: 477-479, 1978.

089. Kaufman, S. Hepatic phenylalanine hydroxylase and PKU. In Buchwald, N. A. & Brazier, M. A. B. (Eds.), Brain mechanisms in mental retardation (pp. 445-458). New York, NY: Academic Press, 1975.

090. Kebabian, J. W. & Calne, D. B. Multiple receptors for dopamine. Nature, 277: 93-96.

091. Klein, D. C. & Seligman, M. E. P. Reversal of performance deficits and perceptual deficits in learned helplessness and depression. Journal of Abnormal Psychology, 85: 11-26, 1976.

092. Kleitman, N. Sleep and Wakefulness. Chicago: University of Chicago Press, 1963.

093. Lagerweij, E., Nelis, P. C., Wiegant, V. M. & van Ree, J. M. The twitch in horses: A variant of acupuncture. Science, 225: 1172-1174, 1984.

094. Lahti, R. A. & Barshun, C. (1974). The effects of minor tranquilizers on stress-induced increases in rat plasma corticosteroids. Psychopharmacologia, 35, 215-220.

095. Langley, J. N. Observations on the physiological action of extracts of the supra-renal bodies. Journal of Physiology (London), 27: 237-256, 1901.

096. Lashley, K. S. Brain Mechanisms and Intelligence. Chicago: University of Chicago Press, 1929.

097. Laudenslager, M. K., Ryan, S. M., Drugan, R. C., Hyson, R. L. & Maier, S. F. Coping and immunosuppression: Inescapable but not escapable shock suppresses lymphocyte proliferation. Science, 221: 568-570, 1983.

098. Leckman, J. F. & Maas, J. W. Plasma MHPG: Relationship to brain noradrenergic systems and emerging clinical applications. In Post, R. M. & Ballenger, J. C. (Eds.) Neurobiology of Mood Disorders (Vol. 1; Ch. 33). Baltimore: William & Wilkins, 1984.

099. Lee, C.-M., Javitz, J. A. & Snyder, S. H. Recognition sites for norepinephrine uptake: Regulation by neurotransmitter. Science, 220: 626-629, 1983.

100. Lewandowsky, M. Ueber eine Wirkung des Nebenniereren-extractes auf das Auge. Zentralbleitung Physiologie, 12: 599-600, 1898.

101. Lewis, J. W., Tordoff, M. G., Sherman, J. E. & Liebeskind, J. C. Adrenal medullary enkephalin-like peptides may mediate opiate stress analgesia. Science, 217: 557-559, 1982.

102. Li, C. H., Barnafi, L., Chretien, M. & Chung, D. Isolation and amino-acid sequence of B-LPH from sheep pituitary glands. Nature, 208: 1093-1094, 1965.

102a. Lippa, A. S., Klepner, C. A., Yunger, L., Sano, M. C., Smith, W. V. & Beer, B. Relationship between benzodiazepine receptors and experimental anxiety in rats. Pharmacology, Biochemistry and Behavior, 9: 853-856, 1978.

103. Loewi, O. & Navratil, E. Ueber humorale Uebertragbarkeit der Herznervenwirkung. X. Mitteilung. Ueber das Schicksal des Vagusstoff. Pflueger's Archiven Gesamte Physiologie, 214: 678-688, 1926.

104. Loewi, O. Ueber humorale Uebertragbarkeit der Herznervenwirkung. Pflueger's Archiven Gesamte Physiologie, 189: 239-242, 1921.

104b. MacQueen, , G., Marshall, J., Perdue, M., Siegel, S., & Bienenstock, J. (1989)

Pavlovian secretion of rat mucosal mast cell protease II. Science, 214, 662-665.

105. Marlatt, G. A. & Rohsenow, D. J. Cognitive processes in alcohol use and expectance and the balanced placebo design. In Mello, N. K. (Ed.) Advances in Substance Abuse, vol. I. Greenwich, CT: JAI Press, Pp. 159-199, 1980.

106. Masserano, J. M., Takimoto, G. S. & Weiner, N. Electroconvulsive shock increases tyrosine hydroxylase activity in the brain and adrenal gland of the rat. Science, 214: 662-665, 1981.

107. Matthews, D. A., Nadler, J. V., Lynch, G. S. & Cotman, C. W. Development of cholinergic innervation in the hippocampal formation of the rat. I. Histochemical demonstration of acetylcholinesterase activity. Developmental Biology, 36: 130-141, 1974.

108. Maugh, T. H. II, Biochemical markers identify mental states. Science, 214: 39-42, 1984.

109. Mayer, D. J., Price, D. D., Barber, J., & Raffi, A. Acupuncture analgesia: Evidence for activation of a pain inhibitory system as a mechanism of action. In: J. J. Bonica & D. G. Albe-Fessard (Eds.), Advances in Pain Research Therapy, Vol. 1, New York: Raven Press, Pp. 751-754, 1976.

110. McAllister, W. R. & McAllister, D. E. Behavioral measurment of conditioned fear. In Brush, F. R. (Ed.), Aversive conditioning and learning. New York, NY: Academic Press, 1971.

111. McCleary, R. A. Response-modulating function of the limbic system: Initiation and suppression. In Stellar, E. & Sprague, J. M. (Eds.), Progress in Physiological Psychology, Vol. 1, New York, NY: Academic Press, 1966.

112. McGrath, A. C. & Kelsey, J. E. Prior exposure to escapable shock reduces the immunosuppressive effects of subsequent inescapable shock. Personal communication, 1983.

112a. McKinney, W. T. & Moran, E. (1984) Animal models of schizophrenia. American Journal of Psychiatry, 138, 478-483.

113. Mendelson, W. B., Cain, M., Cook, J. M., Paul, S. M. & Skolnik, P. A benzodiazepine receptor antagonist decreases sleep and reverses the hypnotic actions of flurazepam. Science, 219: 414-416, 1983.

114. Miczek, K. A., Thompson, M. L. & Shuster, L. Opioid-like analgesia in defeated mice. Science, 215: 1520-1522, 1982.

115. Modigh, K. Effects of social stress on the turnover of brain catecholamines and 5-hydroxytryptamine in mice. Acta Parmacologica et Toxicologica, 34: 97-105, 1974.

116. Modigh, K. Effects of isolation and fighting in mice on the rate of synthesis of noradrenaline, dopamine, and 5-hydroxytryptamine in the brain. Psychopharmacologia, 33: 1-17, 1973.

117. Moehler, H. & Okada, T. (1977). Benzodiazepine receptor: Demonstration in the central nervous system. Science, 198, 849-851.

118. Moore-Ede, M. C., Sulzman, F. M. & Fuller, C. A. The Clocks That Time Us. Cambridge, MA: Harvard University Press, 1982.

119. Moruzzi, G. & Magoun, H. W. Brain stem reticular formation and activation of the EEG. Electroencephalography and Clinical Neurophysiology, 1: 455-473, 1949.

120. Mowrer, O. H. A stimulus-response analysis and its role as a reinforcing agent. Psychological Review, 46: 553-565, 1939.

121. Mowrer, O. H. Two-factor learning theory reconsidered, with special reference to secondary reinforcement and the concept of habit. Psychological Review, 63: 114-128, 1956.

122. Moyer, K. E. & Korn, J. H. Effect of UCS intensity on the acquisition and extinction of an avoidance response. Journal of Experimental Psychology, 67: 352-359, 1964.

123. Nicol, S. E. & Gottesman, I. I. Clues to the genetics and neurobiology of schizophrenia. American Scientist, 71: 398-404, 1983.

124. Olds, J. & Milner, P. Positive reinforcement produced by electrical stimulation of the septal area and other regions of the rat brain. Journal of Comparative and Physiological Psychology, 47: 419-428, 1954.

125. Olson, R. W. The gamma-aminobutyric acid/benzodiazepine/barbiturate receptor-chloride ion channel complex of the mammalian brain. In Edelman, G. M., Gall, W. E., & Cowan, M. E. (Eds.) Synaptic Function. New York, NY: Wiley, 1987, pp. 257-271.

125b. Orne, M. T. (1959) The nature of hypnosis: artifact and essence. Journal of Abnormal and Social Psychology, 58, 277-299.

126. Overmeir, J. B. & Seligman, M. E. P. Effects of inescapable shock upon subsequent escape and avoidance learning. Journal of Comparative and Physiological Psychology, 63: 28-33, 1967.

127. Patrick, J. L. & Lindstrom, J. Autoimmune response to acetylcholine receptor. Science, 180: 871-872, 1973.

128. Pauly, J. E. & Scheving, L. E. Temporal variations in the susceptibility of white rats to pentobarbital sodium and tremorine. International Journal of Neuropharmacology, 3: 651-658, 1964.

129. Pavlov, I. P. Conditioned Reflexes. London: Oxford University Press, 1927.

130. Pendery, M. L., Maltzman, I. M. & West, J. L. Controlled drinking by alcoholics? New findings and a reevaluation of a major affirmative study. Science, 217: 169-175, 1982.

131. Pert, C. B. & Snyder, S. H. Opiate receptor: Its demonstration in nervous tissue. Science, 179: 1011-1014, 1973.

132. Pickar, D., Labarca, R., Linnoila, M., Roy, A., Hommer, D., Everett, D., Paul, S. M. Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients. Science, 225: 954-957, 1984.

133. Poschel, B. P. H. (1971). A simple and specific screen for benzodiazepine-like drugs. Psychopharmacologia, 19, 193-198.

134. Potkin, S. G., Karoum, F., Chuang, L.-W., Cannon-Spoor, H. E., Phillips, I. & Wyatt, R. J. Science, 206: 470-471, 1979.

135. Rall, T. W. Central nervous system stimulants. In, Gilman, A. G., Goodman, L. S. and Gilman, A. (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics (6th Ed.). New York: Macmillan, Pp. 592-607, 1980.

136. Ray, O. Drugs, Society and Human Behavior. 2nd Ed., St. Louis: Mosby, 1978.

137. Remmer, H. Drugs as activators of drug enzymes. In: Metabolic Factors Controlling Duration of Drug Action, Proceedings of First International Pharmacological Meeting, vol. 6, Brodie, B. B. & Erdoes, E. G. (Eds.), New York: Macmillan, 1962.

138. Richter, C. P. On the phenomenon of sudden death in animals and man. Psychosomatic Medicine, 19: 191-198, 1957.

139. Rinaldi, F. & Himwich, H. E. Alerting responses and actions of atropine and cholinergic drugs. Archives of Neurology and Psychiatry, 73: 387-395, 1955.

140. Ritchie, J. M. The aliphatic alcohols. In, Gilman, A. G., Goodman, L. S. and Gilman, A. (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics (6th Ed.). New York: Macmillan, Pp. 376-390, 1980.

140b. Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987). Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science, 237, 1219-1223.

141. Rosenthal, D. The Genain Quadruplets. New York: Basic Books, 1963.

142. Ruch, T. C., Patton, H. D., Woodbury, J. W. & Towe, A. L. Neurophysiology. Philadelphia, PA: Saunders, 1961.

143. Ruch, T. C., Patton, H. D., Woodbury, J. W. & Towe, A. L. Neurophysiology. Philadelphia, PA: Saunders, 1961.

144. Schachter, S. Emotion, Obesity and Crime. New York: Academic Press, 1971.

145. Schachter, S. & Singer, J. E. Cognitive, social, and physiological determinants of emotional state. Psychological Review, 69: 379-399, 1962.

146. Schachter, S. Recidivism and self-cure of smoking and obesity. American Psychologist, 37: 436-444, 1982.

147. Schildkraut, J. J., Orsulak, P. J., Schatzberg, A. F. & Rosenbaum, A. H. Urinary MHPG in affective disorders. In Post, R. M. & Ballenger, J. C. (Eds.) Neurobiology of Mood Disorders (Vol. 1; Ch. 32). Baltimore: William & Wilkins, 1984.

148. Schwartz, R. D. & Keller, K. J. Nicotinic cholinergic receptor binding sites in the brain: Regulation in vivo. Science, 220: 214-216, 1983.

149. Seidel, W. F., Roth, T., Roehrs, T., Zorick, F. & Dement, W. C. Treatment of a 12-hour shift of sleep schedule with benzodiazepines. Science, 224: 1262-1264, 1984.

150. Seiden, L. S., Brown, R. M. & Lewy, A. J., Brain catecholamines and conditioned behavior: mutual interactions. In Sabelli, H. (Ed.), Chemical Modulation of Brain Function. New York: Raven, Pp. 261-276, 1973.

151. Seligman, M. E. P. Helplessness: On Depression, Development, and Death. San Francisco: Freeman, 1975.

152. Seligman, M. E. P., Maier, S. F.& Solomon, R. L. Unpredictable and uncontrollable aversive events. In Brush, F. R. (Ed.), Aversive Conditioning and Learning. New York: Academic Press, 1971.

153. Selye, H. The Stress of Life. New York: McGraw-Hill, 1956.

154. Sepinwall, J. & Cook, L. Behavioral pharmacology of antianxiety drugs. In Iversen, L. L., Iversen, S. D. & Snyder, S. H. (Eds.) Handbook of Psychopharmacology, vol. 13, New York: Plenum Press, 1978.

155. Shavit, Y., Lewis, J. W., Terman, G. W., Gale, R. P. & Liebeskind, J. C. Opioid peptides mediate the suppressive effect of stress on natural killer cell toxicity. Science, 223: 188-190, 1984.

156. Shechter, Y., Maron, R., Elias, D. & Cohen, I. R. Autoantibodies to insulin receptor spontaneously develop as anti-idiotypes in mice immunized with insulin. Science, 216: 542-544, 1984.

157. Sherrington, C. S. (1906) The integrative action of the nervous system. Scribner, NY (2nd Ed., New Haven CT: Yale University Press, 1947).

158. Siegel, S. Conditioning insulin effects. Journal of Comparative and Physiological Psychology, 89: 189-199, 1975.

159. Siegel, S., Hinson, R. E., Krank, M. D. & McCully, J. Heroin overdose death: Contribution of drug-associated environmental cues. Science, 216: 436-437, 1982.

160. Simantov, R. & Snyder, H. Morphine-like peptides in mammalian brain: Isolation, structure elucidation, and interactions with the opiate receptor. Proceedings of the National Academy of Sciences (USA), 73: 2515, 1976.

161. Skinner, B. F. The Behavior of Organisms. An experimental analysis. New York: Appleton-Century-Crofts, 1938.

162. Sklar, L. S. & Anisman, H. Stress and coping factors influence tumor growth. Science, 205: 513-515, 1979.

163. Smith, K., Thompson, G. F. & Koster, H. D. Sweat in schizophrenic patients: Identification of the odorous substance. Science, 166: 398, 1969.

164. Snowdon, C. T. Motivation, regulation and control of meal parameters with oral and intragastric feeding. Journal of Comparative and Physiological Psychology, 69: 91-100, 1969.

165. Snyder, S. H. Drug and neurotransmitter receptors in the brain. Science, 224: 22-31, 1984.

165a Snyder, S. H. (1986) Drugs and the Brain. New York: Scientific American Books.

166. Snyder, S. H. The opiate receptor and morphine-like peptides in the brain. American Journal of Psychiatry, 135: 645-652, 1978.

167. Solomon, R. L. The opponent-process theory of acquired motivation: The costs of pleasure and the benefits of pain. American Psychologist, 35: 691-712, 1980.

168. Solomon, R. L. & Corbit, J. D. An opponent-process theory of motivation: I. Temporal dynamics of affect. Psychological Review, 81: 119-145, 1974.

169. Spence, K. W. Behavior Theory and Conditioning. New Haven: Yale University Press, 1956.

170. Stein, L. Chemistry of purposive behavior. In Tapp, J. (Ed.), Reinforcement and Behavior. New York: Academic Press, 1969.

171. Stein, L. & Wise, C. D. Possible etiology of schizophrenia: Progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science, 171: 1032-1036, 1971.

172. Sternberg, D. E., van Kammen, D. P., Lerner, P. & Bunney, W. E. Schizophrenia: Dopamine B-hydroxylase activity and treatment response. Science, 216: 1423-1425, 1982.

173. Tapp, J. T. Activity, reactivity, and the behavior-directing properties of stimuli. In Tapp, J. T. (Ed.) Reinforcement and Behavior. New York: Academic Press, Pp. 148-178, 1969.

174. Taylor, P. Cholinergic agonists. In Gilman, A. G., Goodman, L. S. and Gilman, A. (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics (6th Ed.). New York: Macmillan, Pp. 91-99, 1980.

175. Taylor, M. A. Schizoaffective and allied disorders. In Post, R. M. & Ballenger, J. C. (Eds.), Neurobiology of Mood Disorders (Vol. 1; Ch. 9). Baltimore: William & Wilkins, 1984.

176. Teitelbaum, P. & Stellar, E. Recovery from the failure to eat, produced by hypothalamic lesions. Science, 120: 894-895, 1954.

177. Teitelbaum, P. and Epstein, A. N. (1962) The lateral hypothalamic syndrome. Psychological Review, 69: 74-90, 1962.

178. Thoenen, H. & Tranzer, J. P. The pharmacology of 6-hydroxydopamine. Annual Review of Pharmacology, 13: 169-180, 1973.

179. Thudicum, J. W. L. A Treatise on the Chemical Constitution of the Brain. London: Balliere, Tindale & Cox, 1884.

179a. Traeksman, L., Asberg, M., Bertilsson, L., & Sjoestrand, L. (1981) Monoamine metabolites in CSF and suicidal behavior. Archives of General Psychiatry, 38, 631-636.

180. Trulson, M. E. & Jacobs, B. L. Long-term amphetamine treatment decreases brain serotonin metabolism: Implications for theories of schizophrenia. Science, 205: 1295-1297, 1979.

181. Uttal, W. R. The Psychobiology of Mind. Hillsdale, NJ: Erlbaum, 1978.

182. Valenstein, E. S. Brain control. New York, NY: Wiley, 1973.

183. Van Kammer, D. P., Mann, L. S., Sternberg, D. E., Scheinin, M. E., Ninan, P. T., Marder, S. R., van Kammen, W. B., Reider, R. O. & Linnoila, M. Dopamine B-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy. Science, 220: 974-977, 1983.

184. Visintainer, M. A., Volpicelli, J. R. & Seligman, M. E. P. Tumor rejection in rats after escapable or inescapable shock. Science, 216: 437-439, 1982.

185. Volavka, J., Davis, L. G. & Davis, Y. H. Endorphins, dopamine, and schizophrenia. Schizophrenia Bulletin, 5: 227-239, 1979.

186. Wada, J. & Rasmussen, T. Intracarotid injection of sodium amytal for the lateralization of speech dominance. Journal of Neurosurgery, 17: 266-282, 1960.

187. Watkins, L. R. & Mayer, D. J. Organization of endogenous opiate and nonopiate pain control systems. Science, 216: 1185-1192, 1982.

188. Watson, J. B. & Rayner, R. Conditioned emotional reactions. Journal of Experimental Psychology, 3, 1-14, 1920.

189. Webb, W. Sleep: The Gentle Tyrant. Englewood Cliffs, NJ: Prentice-Hall, 1975.

190. Weiner, N. Atropine, scopolamine, and related antimuscarinic drugs. In, Gilman, A. G., Goodman, L. S. and Gilman, A. (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics (6th Ed.). New York: Macmillan, Pp. 120-137, 1980a.

191. Weiner, N. Norepinephrine, epinephrine, and the sympathomimetic amines. In, Gilman, A. G., Goodman, L. S. and Gilman, A. (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics (6th Ed.). New York: Macmillan, Pp. 138-175, 1980b.

192. Weiss, J. M., Goodman, P. R., Losito, B. G., Corrigan, S., Charry, J. M. & Bailey, W. H. Stressor: Relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain. Brain Research Reviews, 3: 167-205, 1981.

193. Weiss, J. M. Effects of coping responses on stress. Journal of Comparative and Physiological Psychology, 65: 251-260, 1968.

194. Weiss, J. M. (1971a) Effects of coping behavior in different warning signal conditions on stress pathology in rats. Journal of Comparative and Physiological Psychology, 77, 1-13.

195. Weiss, J. M. (1971b) Effects of punishing the coping response (conflict) on stress pathology in rats. Journal of Comparative and Physiological Psychology, 77, 14-21.

196. Weiss, J. M. (1971c) Effects of coping behavior with and without a feedback signal on stress pathology in rats. Journal of Comparative and Physiological Psychology, 77, 22-30.

197. Welch, B. L. & Welch, A. S. Aggression and the biogenic amine neurohumors. In Garattini, S. & Sigg, E. B. (Eds.), Aggressive Behavior. Amsterdam: Excerpta Medica Foundation, Pp. 179-189, 1969.

198. Wenger, J. R., Tiffany, T. M., Bombardier, C., Nicholls, K., & Woods, S. C. Ethanol tolerance in the rat is learned. Science, 213: 575-577, 1981.

199. Wise, C. D. & Stein, L. Dopamine-B-hydroxylase deficits in the brains of schizophrenic patients. Science, 181: 344-347, 1973.

200. Yerkes, R. M. & Dodson, J. D. The relation of strength of stimulus to rapidity of habit-formation. Journal of Comparative Neurology and Physiology, 18: 458-482, 1908.

201. Zahn, T. P., Rapoport, J. L. & Thompson, C. L. Autonomic and behavioral effects of dextroamphetamine and placebo in normal and hyperactive prepubertal boys. Journal of Abnormal Child Psychology. 8: 145-160, 1980.